메뉴 건너뛰기




Volumn 15, Issue 1, 2013, Pages 49-60

Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through bim overexpression: Implications for cancer treatment

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; DOXORUBICIN; NAVELBINE; PACLITAXEL; PROTEIN BCL 2; TRANSCRIPTION FACTOR FKHRL1;

EID: 84873037229     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121074     Document Type: Article
Times cited : (45)

References (57)
  • 1
    • 37449016064 scopus 로고    scopus 로고
    • Microtubules in apoptosis induction: Are they necessary?
    • Estève M-A, Carré M, and Braguer D (2007). Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targets 7, 713-729.
    • (2007) Curr Cancer Drug Targets , vol.7 , pp. 713-729
    • Estève, M-A.1    Carré, M.2    Braguer, D.3
  • 2
    • 29344471072 scopus 로고    scopus 로고
    • Understanding microtubule dynamics for improved cancer therapy
    • Honore S, Pasquier E, and Braguer D (2005). Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci 62, 3039-3056.
    • (2005) Cell Mol Life Sci , vol.62 , pp. 3039-3056
    • Honore, S.1    Pasquier, E.2    Braguer, D.3
  • 3
    • 77954762893 scopus 로고    scopus 로고
    • Olesoxime prevents microtubule-targeting drug neurotoxicity: Selective preservation of EB comets in differentiated neuronal cells
    • Rovini A, Carré M, Bordet T, Pruss RM, and Braguer D (2010). Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. Biochem Pharmacol 80, 884-894.
    • (2010) Biochem Pharmacol , vol.80 , pp. 884-894
    • Rovini, A.1    Carré, M.2    Bordet, T.3    Pruss, R.M.4    Braguer, D.5
  • 4
    • 0037021417 scopus 로고    scopus 로고
    • Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
    • André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, and Braguer D (2002). Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett 532, 256-260.
    • (2002) FEBS Lett , vol.532 , pp. 256-260
    • André, N.1    Carré, M.2    Brasseur, G.3    Pourroy, B.4    Kovacic, H.5    Briand, C.6    Braguer, D.7
  • 5
    • 73149112184 scopus 로고    scopus 로고
    • Bim-targeted cancer therapy: A link between drug action and underlyingmolecular changes
    • Akiyama T, Dass CR, and Choong PFM (2009). Bim-targeted cancer therapy: a link between drug action and underlyingmolecular changes. MolCancerTher 8, 3173-3180.
    • (2009) MolCancerTher , vol.8 , pp. 3173-3180
    • Akiyama, T.1    Dass, C.R.2    Choong, P.F.M.3
  • 7
    • 38849099158 scopus 로고    scopus 로고
    • Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization
    • Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, et al. (2008). Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14, 193-204.
    • (2008) Dev Cell , vol.14 , pp. 193-204
    • Cassidy-Stone, A.1    Chipuk, J.E.2    Ingerman, E.3    Song, C.4    Yoo, C.5    Kuwana, T.6    Kurth, M.J.7    Shaw, J.T.8    Hinshaw, J.E.9    Green, D.R.10
  • 8
    • 0035166814 scopus 로고    scopus 로고
    • Dynaminrelated protein Drp1 is required for mitochondrial division in mammalian cells
    • Smirnova E, Griparic L, Shurland DL, and Van der Bliek AM (2001). Dynaminrelated protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12, 2245-2256.
    • (2001) Mol Biol Cell , vol.12 , pp. 2245-2256
    • Smirnova, E.1    Griparic, L.2    Shurland, D.L.3    Van der Bliek, A.M.4
  • 9
    • 78149359813 scopus 로고    scopus 로고
    • Mitochondrial fission/fusion dynamics and apoptosis
    • Sheridan C and Martin SJ (2010). Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 10, 640-648.
    • (2010) Mitochondrion , vol.10 , pp. 640-648
    • Sheridan, C.1    Martin, S.J.2
  • 10
    • 70449107007 scopus 로고    scopus 로고
    • Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis
    • Autret A and Martin SJ (2009). Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 36, 355-363.
    • (2009) Mol Cell , vol.36 , pp. 355-363
    • Autret, A.1    Martin, S.J.2
  • 12
  • 13
    • 0037050735 scopus 로고    scopus 로고
    • Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
    • Sartorius UA and Krammer PH (2002). Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer 97, 584-592.
    • (2002) Int J Cancer , vol.97 , pp. 584-592
    • Sartorius, U.A.1    Krammer, P.H.2
  • 14
  • 15
    • 70449723145 scopus 로고    scopus 로고
    • 5-Year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen
    • O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki AB, Koziner B, Chanan-Khan AA, Seymour JF, Gribben J, ItriLM, et al. (2009). 5-Year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen. J Clin Oncol 27, 5208-5212.
    • (2009) J Clin Oncol , vol.27 , pp. 5208-5212
    • O'Brien, S.1    Moore, J.O.2    Boyd, T.E.3    Larratt, L.M.4    Skotnicki, A.B.5    Koziner, B.6    Chanan-Khan, A.A.7    Seymour, J.F.8    Gribben, J.9    Itri, L.M.10
  • 16
    • 39749166555 scopus 로고    scopus 로고
    • Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103
    • Rudin CM, Salgia R, Wang X, Hodgson LD, Masters GA, Green M, and Vokes EE (2008). Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J Clin Oncol 26, 870-876.
    • (2008) J Clin Oncol , vol.26 , pp. 870-876
    • Rudin, C.M.1    Salgia, R.2    Wang, X.3    Hodgson, L.D.4    Masters, G.A.5    Green, M.6    Vokes, E.E.7
  • 17
    • 67650360358 scopus 로고    scopus 로고
    • Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): An EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
    • Sternberg CN, Dumez H, Van Poppel H, Skoneczna I, Sella A, Daugaard G, Gil T, Graham J, Carpentier P, Calabro F, et al. (2009). Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer. Ann Oncol 20, 1264-1269.
    • (2009) Ann Oncol , vol.20 , pp. 1264-1269
    • Sternberg, C.N.1    Dumez, H.2    Van Poppel, H.3    Skoneczna, I.4    Sella, A.5    Daugaard, G.6    Gil, T.7    Graham, J.8    Carpentier, P.9    Calabro, F.10
  • 20
    • 0036893309 scopus 로고    scopus 로고
    • Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used
    • Del Bufalo D, Biroccio A, Trisciuoglio D, Bruno T, Floridi A, Aquino A, and Zupi G (2002). Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used. Eur J Cancer 38, 2455-2462.
    • (2002) Eur J Cancer , vol.38 , pp. 2455-2462
    • Del Bufalo, D.1    Biroccio, A.2    Trisciuoglio, D.3    Bruno, T.4    Floridi, A.5    Aquino, A.6    Zupi, G.7
  • 22
  • 23
    • 14944349359 scopus 로고    scopus 로고
    • Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim
    • Li R, Moudgil T, Ross HJ, and Hu H-M (2005). Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ 12, 292-303.
    • (2005) Cell Death Differ , vol.12 , pp. 292-303
    • Li, R.1    Moudgil, T.2    Ross, H.J.3    Hu, H-M.4
  • 24
    • 52949107914 scopus 로고    scopus 로고
    • Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria
    • Khawaja NR, Carré M, Kovacic H, Estève MA, and Braguer D (2008). Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria. Mol Pharmacol 74, 1072-1083.
    • (2008) Mol Pharmacol , vol.74 , pp. 1072-1083
    • Khawaja, N.R.1    Carré, M.2    Kovacic, H.3    Estève, M.A.4    Braguer, D.5
  • 25
    • 63149129655 scopus 로고    scopus 로고
    • Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy
    • Kang MH and Reynolds CP (2009). Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15, 1126-1132.
    • (2009) Clin Cancer Res , vol.15 , pp. 1126-1132
    • Kang, M.H.1    Reynolds, C.P.2
  • 26
    • 0033104996 scopus 로고    scopus 로고
    • The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex
    • Puthalakath H, Huang DC, O'Reilly LA, King SM, and Strasser A (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3, 287-296.
    • (1999) Mol Cell , vol.3 , pp. 287-296
    • Puthalakath, H.1    Huang, D.C.2    O'Reilly, L.A.3    King, S.M.4    Strasser, A.5
  • 29
    • 0035135841 scopus 로고    scopus 로고
    • Protein kinase SGK mediates survival signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a)
    • Brunet A, Park J, Tran H, Hu LS, Hemmings BA, and Greenberg ME (2001). Protein kinase SGK mediates survival signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21, 952-965.
    • (2001) Mol Cell Biol , vol.21 , pp. 952-965
    • Brunet, A.1    Park, J.2    Tran, H.3    Hu, L.S.4    Hemmings, B.A.5    Greenberg, M.E.6
  • 30
    • 0031666237 scopus 로고    scopus 로고
    • Differentiation and programmed cell deathrelated intermediate biomarkers for the development of non-small cell lung cancer: A pilot study
    • Zhang H, Yousem SA, Franklin WA, Elder E, Landreneau R, Ferson P, Keenan R, Whiteside T, and Levitt ML (1998). Differentiation and programmed cell deathrelated intermediate biomarkers for the development of non-small cell lung cancer: a pilot study. Hum Pathol 29, 965-971.
    • (1998) Hum Pathol , vol.29 , pp. 965-971
    • Zhang, H.1    Yousem, S.A.2    Franklin, W.A.3    Elder, E.4    Landreneau, R.5    Ferson, P.6    Keenan, R.7    Whiteside, T.8    Levitt, M.L.9
  • 31
    • 0030868245 scopus 로고    scopus 로고
    • Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line
    • Del Bufalo D, Biroccio A, Leonetti C, and Zupi G (1997). Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J 11, 947-953.
    • (1997) FASEB J , vol.11 , pp. 947-953
    • Del Bufalo, D.1    Biroccio, A.2    Leonetti, C.3    Zupi, G.4
  • 32
    • 84860724888 scopus 로고    scopus 로고
    • Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer
    • Gao Q, Yang S, and Kang M-Q (2012). Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Mol Med Report 5, 1409-1414.
    • (2012) Mol Med Report , vol.5 , pp. 1409-1414
    • Gao, Q.1    Yang, S.2    Kang, M-Q.3
  • 33
    • 67349152903 scopus 로고    scopus 로고
    • BimL upregulation induced by BCR cross-linking in BL41 Burkitt's lymphoma results from a splicing mechanism of the BimEL mRNA
    • Clybouw C, Hadji A, ElMchichi B, Auffredou M-T, Leca G, and Vazquez A (2009). BimL upregulation induced by BCR cross-linking in BL41 Burkitt's lymphoma results from a splicing mechanism of the BimEL mRNA. Biochem Biophys Res Commun 383, 32-36.
    • (2009) Biochem Biophys Res Commun , vol.383 , pp. 32-36
    • Clybouw, C.1    Hadji, A.2    El-McHichi, B.3    Auffredou, M-T.4    Leca, G.5    Vazquez, A.6
  • 34
    • 0027360552 scopus 로고
    • Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
    • Jordan MA, Toso RJ, Thrower D, and Wilson L (1993). Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90, 9552-9556.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 9552-9556
    • Jordan, M.A.1    Toso, R.J.2    Thrower, D.3    Wilson, L.4
  • 35
    • 0026671039 scopus 로고
    • Taxol: A review of its preclinical in vivo antitumor activity
    • Rose WC (1992). Taxol: a review of its preclinical in vivo antitumor activity. Anticancer Drugs 3, 311-321.
    • (1992) Anticancer Drugs , vol.3 , pp. 311-321
    • Rose, W.C.1
  • 36
    • 0028224041 scopus 로고
    • Study for modifying activity of solvents on antitumor activity of paclitaxel
    • Fujimoto S (1994). Study for modifying activity of solvents on antitumor activity of paclitaxel. Gan To Kagaku Ryoho 21, 665-670.
    • (1994) Gan To Kagaku Ryoho , vol.21 , pp. 665-670
    • Fujimoto, S.1
  • 37
    • 7444269580 scopus 로고    scopus 로고
    • Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway
    • Pasquier E, Carré M, Pourroy B, Camoin L, Rebaï O, Briand C, and Braguer D (2004). Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. Mol Cancer Ther 3, 1301-1310.
    • (2004) Mol Cancer Ther , vol.3 , pp. 1301-1310
    • Pasquier, E.1    Carré, M.2    Pourroy, B.3    Camoin, L.4    Rebaï, O.5    Briand, C.6    Braguer, D.7
  • 39
    • 79955575758 scopus 로고    scopus 로고
    • Microtubule-targeted agents: When mitochondria become essential to chemotherapy
    • Rovini A, Savry A, Braguer D, and Carré M (2011). Microtubule-targeted agents: when mitochondria become essential to chemotherapy. Biochim Biophys Acta 1807, 679-688.
    • (2011) Biochim Biophys Acta , vol.1807 , pp. 679-688
    • Rovini, A.1    Savry, A.2    Braguer, D.3    Carré, M.4
  • 40
    • 1242272838 scopus 로고    scopus 로고
    • Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells
    • Chun E and Lee K-Y (2004). Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 315, 771-779.
    • (2004) Biochem Biophys Res Commun , vol.315 , pp. 771-779
    • Chun, E.1    Lee, K-Y.2
  • 41
    • 0036165679 scopus 로고    scopus 로고
    • In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions
    • Koty PP, Zhang H, Franklin WA, Yousem SA, Landreneau R, and Levitt ML (2002). In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions. Lung Cancer 35, 155-163.
    • (2002) Lung Cancer , vol.35 , pp. 155-163
    • Koty, P.P.1    Zhang, H.2    Franklin, W.A.3    Yousem, S.A.4    Landreneau, R.5    Levitt, M.L.6
  • 42
    • 0036517358 scopus 로고    scopus 로고
    • Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder
    • Uchida T, Minei S, Gao J-P, Wang C, Satoh T, and Baba S (2002). Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder. Oncol Rep 9, 253-259.
    • (2002) Oncol Rep , vol.9 , pp. 253-259
    • Uchida, T.1    Minei, S.2    Gao, J-P.3    Wang, C.4    Satoh, T.5    Baba, S.6
  • 47
    • 15844382488 scopus 로고    scopus 로고
    • p53 stimulates promoter activity of the sgk serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells
    • Maiyar AC, Huang AJ, Phu PT, Cha HH, and Firestone GL (1996). p53 stimulates promoter activity of the sgk serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 271, 12414-12422.
    • (1996) J Biol Chem , vol.271 , pp. 12414-12422
    • Maiyar, A.C.1    Huang, A.J.2    Phu, P.T.3    Cha, H.H.4    Firestone, G.L.5
  • 49
    • 33847077943 scopus 로고    scopus 로고
    • FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells
    • Obexer P, Geiger K, Ambros PF, Meister B, and Ausserlechner MJ (2007). FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 14, 534-547.
    • (2007) Cell Death Differ , vol.14 , pp. 534-547
    • Obexer, P.1    Geiger, K.2    Ambros, P.F.3    Meister, B.4    Ausserlechner, M.J.5
  • 50
  • 52
    • 84866641257 scopus 로고    scopus 로고
    • Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model
    • Thomas KJ and Jacobson MR (2012). Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model. PLoS One 7, e45319.
    • (2012) PLoS One , vol.7
    • Thomas, K.J.1    Jacobson, M.R.2
  • 53
    • 64049095817 scopus 로고    scopus 로고
    • BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3
    • Nordigården A, Kraft M, Eliasson P, Labi V, Lam EW-F, Villunger A, and Jönsson JI (2009). BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3. Blood 113, 2302-2311.
    • (2009) Blood , vol.113 , pp. 2302-2311
    • Nordigården, A.1    Kraft, M.2    Eliasson, P.3    Labi, V.4    Lam, E.W.-F.5    Villunger, A.6    Jönsson, J.I.7
  • 54
    • 35648953299 scopus 로고    scopus 로고
    • Gefitinibinduced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
    • discussion 1690
    • CraggMS, Kuroda J, PuthalakathH, HuangDCS, and Strasser A (2007). Gefitinibinduced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med 4, 1681-1689; discussion 1690.
    • (2007) PLoS Med , vol.4 , pp. 1681-1689
    • Cragg, M.S.1    Kuroda, J.2    Puthalakath, H.3    Huang, D.C.S.4    Strasser, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.